Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Not applicable

Stories That Empower Mothers and Postpartum Depression

NCT06787300 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2021-04-01
Last updated
2025-01-22

Condition(s) studied

Postpartum Depression

Investigational drug(s) / intervention(s)

Stories that Empowered Mother

Stories that Empowered Mother: this intervention is made by resercher for this research.

Study summary

Postpartum depression is a condition that occurs after birth and is difficult for mothers. Research shows that experiencing postpartum depression once increases the risk of experiencing it in subsequent pregnancies. At the same time, there are findings in the literature that pregnant women with postpartum depression experience mental difficulties, anxiety or depression during pregnancy. For this reason, this study aims to determine the risk of postpartum depression in pregnant women who are pregnant for the first time during pregnancy and to prevent this risk from occurring in the postpartum period. For this purpose, 'Stories to empower mothers' programme was created. This programme was created by researchers who are specialist psychiatric nurses, psychotherapists and art therapists and finalised with expert opinions. The programme consists of six sessions. The sessions are individual and are conducted online except for the first session. A storybook is formed at the end of the programme with the steps followed during the sessions. While creating this storybook, the themes of self-knowledge, defining the situation, identifying difficulties, identifying sources of help, discovering strengths and creating new coping strategies are addressed by using art therapy techniques. The aim of the study is to examine the effect of the 'Stories Empowering Mothers Programme' on the risk of postpartum depression in pregnant women experiencing their first pregnancy.

The research is conducted in a non-randomised experimental follow-up research design. Pregnant women who meet the inclusion criteria of the study can be included in the experimental or control group according to their wishes. The data collection process in the study proceeds in the order of determining the target group, pre-test (24-32nd gestational week), post-test (after 5 weeks), follow-up one test (postpartum 2nd-4th week) and follow-up two tests (postpartum 10th-12th week). The data are obtained with the Case Report Form and Postpartum Information Form prepared by the researcher and EPDI, BDI and Brief Psychological Resilience Scale forms.

Expert support will be obtained for statistical analyses. Ethics committee permission was obtained before the research was started to be conducted. The research is a doctoral thesis supported by TÜBİTAK.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * First pregnancy, * Singleton pregnancy, * Gestational week between 24-32, * Regular doctor follow-up, * Scored ≥ 10 on the EDBS, * Scored \< 17 on the BDI, * Literate, * No disability in sensory organs that would prevent communication, * Owning a smart phone or computer, * Having internet access, * Volunteering Exclusion Criteria: * Being in the first trimester of pregnancy, * Being treated/therapized with any psychiatric diagnosis, * Having a risky pregnancy, * Being at risk of premature birth and developing it, * Having any complications related to pregnancy (gestational diabetes, hypertension, bleeding, etc.), * The baby is not healthy, * Developing complications during and after birth, * The baby needs intensive care after birth, * Having a baby lost, * Having a premature birth (\<37 weeks), * The mother has experienced serious daily life difficulties (disaster, loss, etc.), * Not attending three or more of the six sessions

Primary outcome measure(s)

  • Case Report Form — 24 - 32. gestational week
    The case report form created by the researcher is a form consisting of questions regarding the contact information, age, marital status, pregnancy information, whether the pregnancy was desired, and whether any treatment was received for the pregnancy of the pregnant women participating in the study. The case report form will be applied to all pregnant women in order to determine the sample group.
  • Edinburgh postpartum depression scale — pre-test( 24 - 32. gestational week), post-test( (30 to 38 weeks of gestation, 6 weeks after the pretest) , follow-up 1 test, (2 - 4. postnatal week), follow-up 2 test (10 -12. postanal week)
    It was developed by Cox et al. in 1987, and its validity and reliability have been tested in many countries and different languages to date, and its validity and reliability study in our country was conducted by Engindeniz et al. (1996). The scale consists of 10 items. The items are evaluated in a 4-point Likert format and are scored between 0-3. The lowest score that can be obtained from the scale is 0, and the highest score is 30. Each item in the scale is evaluated as 0, 1, 2, 3, and the scoring is reversed (3, 2, 1, 0) in the evaluation of items 3, 5, 6, 7, 8, 9, and 10.
  • Beck Depression Inventory — pre- test( 24 - 32. gestational week),
    eck Depression Inventory is a four-point Likert-type self-assessment scale developed by Beck et al. (1961) to measure the physical, emotional, cognitive and motivational components of depression. The scale is graded between '0-3' and consists of 21 questions. The minimum and maximum values of the scale are 0-63. Although depression is assessed in four degrees on the scale; 5-9 points indicate normal, 10-16 points indicate mild-moderate, 17-29 points indicate moderate-severe and 30-63 points indicate severe depression (Beck et al., 1961). The inventory will be used to support an inclusion-exclusion criterion in determining the target population of the research.
  • Brief Resilience Scale — pre-test( 24 - 32. gestational week), post-test(30 to 38 weeks of gestation, 6 weeks after the pretest)
    The scale was developed by Smith et al. (2008) to measure the psychological resilience of individuals. KPSS is a 5-point Likert-type, 6-item, self-reporting measurement tool. Items 2, 4 and 6 are reverse coded. KPSS is a 5-point Likert-type scale. It has an answer key of "Not at all appropriate" (1), "Not appropriate" (2), "Somewhat appropriate" (3), "Appropriate" (4), "Completely appropriate" (5). After the reverse coded items in the scale are translated, high scores indicate high psychological resilience.
  • Postpartum Information Form — Follow-up 1 test, (2 - 4. postnatal week)
    The postpartum interview form is a form that will be applied to both the experimental and control groups after the women give birth. The form evaluates the women's birth dates, birth methods, and whether they received support during the postpartum period.

Trial sites (1)

FacilityCityRegionStatus
Ege University Izmir Turkey (Türkiye) Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06787300 on ClinicalTrials.gov ↗ ← All trials in Turkey